Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 aPriori aPriori +195.44%
#4 Bedrock Bedrock +78.59%
#5 Cysic Cysic +52.73%
#6 Prom Prom +41.94%
#7 Playnance Playnance +35.03%
#8 Bitway Bitway +27.63%
#9 Nillion Nillion +23.82%
#10 COTI COTI +23.81%
Coin of the day
Wrapped One Wrapped One
설정
언어
한국어
통화
USD
테마
Life Stem Genetics Inc. Life Stem Genetics Inc.

Life Stem Genetics Inc.

LIFS
주식 순위 #42117
Life Stem Genetics Inc., an enterprise currently in its development phase, is... Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
주가
$0.0001
시가총액
$4.58K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Life Stem Genetics Inc. (LIFS)

카테고리

Healthcare
Life Stem Genetics Inc. (LIFS)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Life Stem Genetics Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Life Stem Genetics Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR